Samrat Pharmachem Ltd.
BSE: 530125 | Sector: Health care |
NSE: N.A. | ISIN Code: INE103E01016 |
BSE 00:00 | 05 Jul | 452.40 |
11.25 (2.55%) |
OPEN
449.90 |
HIGH
459.30 |
LOW
433.00 |
NSE 05:30 | 01 Jan | Samrat Pharmachem Ltd |
OPEN | 449.90 |
PREVIOUS CLOSE | 441.15 |
VOLUME | 3602 |
52-Week high | 578.00 |
52-Week low | 170.00 |
P/E | 8.13 |
Mkt Cap.(Rs cr) | 140 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Samrat Pharmachem Ltd. (SAMRATPHARMA) - Financial Ratios
Ratios | 2021 | 2020 | 2019 |
Debt-Equity Ratio | 0.34 | 0.36 | 0.41 |
Current Ratio | 1.57 | 1.53 | 1.61 |
Asset turnover ratio | 16.07 | 14.05 | 11.64 |
Inventory turnover ratio | 13.55 | 11.77 | 16.96 |
Debtors turnover ratio | 6.72 | 6.43 | 5.84 |
Interest Coverage ratio | 6.73 | 6.91 | 3.04 |
Operating Margin (%) | 4.46 | 4.58 | 2.90 |
Net Profit Margin (%) | 2.61 | 2.70 | 1.23 |
Return on Capital Employed (%) | 23.90 | 22.38 | 11.73 |
Return on Net Worth (%) | 19.76 | 19.11 | 7.98 |
Quick Links for Samrat Pharmachem:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices